1. Home
  2. PSTV vs DGLY Comparison

PSTV vs DGLY Comparison

Compare PSTV & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • DGLY
  • Stock Information
  • Founded
  • PSTV 1996
  • DGLY N/A
  • Country
  • PSTV United States
  • DGLY United States
  • Employees
  • PSTV N/A
  • DGLY N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PSTV Health Care
  • DGLY Technology
  • Exchange
  • PSTV Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • PSTV 10.4M
  • DGLY 8.4M
  • IPO Year
  • PSTV N/A
  • DGLY N/A
  • Fundamental
  • Price
  • PSTV $1.77
  • DGLY $2.38
  • Analyst Decision
  • PSTV Strong Buy
  • DGLY
  • Analyst Count
  • PSTV 1
  • DGLY 0
  • Target Price
  • PSTV $8.00
  • DGLY N/A
  • AVG Volume (30 Days)
  • PSTV 42.3K
  • DGLY 27.9K
  • Earning Date
  • PSTV 08-12-2024
  • DGLY 08-12-2024
  • Dividend Yield
  • PSTV N/A
  • DGLY N/A
  • EPS Growth
  • PSTV N/A
  • DGLY N/A
  • EPS
  • PSTV N/A
  • DGLY N/A
  • Revenue
  • PSTV $6,084,000.00
  • DGLY $26,080,507.00
  • Revenue This Year
  • PSTV $5.21
  • DGLY $22.14
  • Revenue Next Year
  • PSTV N/A
  • DGLY N/A
  • P/E Ratio
  • PSTV N/A
  • DGLY N/A
  • Revenue Growth
  • PSTV 733.42
  • DGLY N/A
  • 52 Week Low
  • PSTV $0.97
  • DGLY $1.73
  • 52 Week High
  • PSTV $3.21
  • DGLY $4.40
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 48.74
  • DGLY 48.69
  • Support Level
  • PSTV $1.74
  • DGLY $2.04
  • Resistance Level
  • PSTV $1.97
  • DGLY $2.65
  • Average True Range (ATR)
  • PSTV 0.16
  • DGLY 0.17
  • MACD
  • PSTV 0.04
  • DGLY 0.03
  • Stochastic Oscillator
  • PSTV 55.22
  • DGLY 59.33

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: